HCWB: HCW Biologics Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 51.06
Enterprise Value ($M) 53.89
Book Value ($M) 13.46
Book Value / Share 0.36
Price / Book 3.79
NCAV ($M) -8.65
NCAV / Share -0.23
Price / NCAV -5.90

Profitability (mra)
Return on Invested Capital (ROIC) -1.26
Return on Assets (ROA) -0.57
Return on Equity (ROE) -0.77

Liquidity (mrq)
Quick Ratio 0.73
Current Ratio 0.73

Balance Sheet (mrq) ($M)
Current Assets 6.40
Assets 28.51
Liabilities 15.05
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 2.84
Operating Income -25.72
Net Income -24.99

Cash Flow Statement (mra) ($M)
Cash From Operations -22.51
Cash from Investing 3.80
Cash from Financing -0.01

(click for more detail)
Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-04-01 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K
2023-11-14 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q
2023-08-11 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q
2023-08-10 10-Q/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q/A (Amendment No. 1)
2023-05-09 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-05-03 145 5,199 2.79
2024-05-02 2,225 226 984.51
2024-05-01 763 30 2,543.33
2024-04-30 2,530 1,808 139.93
2024-04-29 404 205 197.07

(click for more detail)

Similar Companies
GHRS – GH Research PLC GLYC – GlycoMimetics, Inc.
GRTX – Galera Therapeutics, Inc. HRMY – Harmony Biosciences Holdings, Inc.
HROW – Harrow, Inc.


Financial data and stock pages provided by
Fintel.io